Trial
NCT01036802
Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Pulmonary Hypertension
Intervention
Warfarin
Why stopped
Difficulty in accruing subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-09